Skip to main content
. 2022 Oct 24;60(12):530–538. doi: 10.5414/CP204257

Table 1. Overall study design.

Screening Allocation Before dosing Dosing (1st, 2nd, and 3rd term)
0.0 h 0.5 h 1 h 2 h 4 h 8 h 12 h 24 h
Informed consent
Background survey
Medical examination
Physical examination
Vital sign measurement
Blood test
Blood draw
Urine test
Behavior recording <---- ----- ----- ----- ----- ----- ----- ---->
Meal